U.S. 3D Bioprinting Market - By Component (3D Bioprinters [Micro Extrusion Bioprinters, Inkjet 3D Bioprinters, Laser-Assisted Bioprinters, Stereolithography-Based Bioprinters, Magnetic 3D Bioprinters,... ... etic 3D Bioprinters, Other 3D Bioprinters], Bioinks [Natural Bioinks, Hybrid Bioinks, Synthetic Bioinks], Software, Consumables), By Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials), By Application (Research Applications [Drug Research, Regenerative Medicine, 3D Cell Culture], Clinical Applications [Skin, Bone & Cartilage, Blood Vessels, Other Clinical Applications]), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals) and others Read more
- Healthcare
- Jan 2025
- 121
- PDF, Excel, PPT
Market Definition
3D bioprinting is a technique used to develop cells, tissues, and organs such as skin, ears, bladders, etc., that are exactly similar to those inside the human body.
Market Insights & Analysis: U.S. 3D Bioprinting Market (2025-30):
The U.S. 3D Bioprinting Market size was valued at around USD688 million in 2024 and is projected to reach USD1,887 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 17.88% during the forecast period, i.e., 2025-30. The main reason behind this growth is the high demand for developing drugs that have high efficacy and that too in the least possible time. Doing clinical trials on the models made using 3D bioprinters helps in doing frequent tests and hence reducing the development time of a new drug by around 60%. Additionally, the use of such devices in the cosmetic industry has helped them develop skins for their consumers that accurately mimic their skin texture, i.e., color, glow, and all other parameters.
Moreover, the US government has banned the testing of new drugs on animals, i.e., the Federal Food, Drug, and Cosmetics Act of 1938 which mandates the test of new drugs on animals before human trials animals. This poses a challenge for pharmaceutical clinical trials which is addressed by the use of 3D-printed tissues and cells as they are similar to the ones present in the human body and help in knowing the precise impacts of the solutions developed. As a result, the demand for printers that are used to develop such models increases, and this demand is expected to increase in the coming years amid the increasing number of drug trials in the US.
| Report Coverage | Details |
|---|---|
| Historical Years | 2020-23 |
|
Base Years
|
2024
|
|
Forecast Years
|
2025-30
|
| Market Value in 2024 | USD688 million |
| Market Value in 2030 | USD1,887 million |
| CAGR (2025-30) | 17.88% |
| Top Key Players | CELLINK, Organovo, Aspect Biosystems, Allevi, Prellis Biologics, Stratasys, Advanced Solutions Life Sciences, LLC, regenHU Ltd, Poietis, 3D Bioprinting, others |
| Key Report Highlights |
|
Furthermore, the US has a very high focus on research and development processes. Their expenditures include spending on the development of new drugs with high efficacy and developing body organs that can be implanted inside the human body. For instance, the Center for Drug Evaluation and Research (CDER) approved around 55 drugs in 2023, and the cost included in the R&D processes of such medicines is more than USD314 million and goes up to USD4.46 billion for every such drug. This results in increasing demand for 3D bioprinting devices which are utilized in measuring the outcomes of such processes.
Hence superior advantages offered by these devices to various industries like cosmetics, pharmaceuticals, etc. have resulted in high growth of this market, which is expected to continue in the forecast period too
*Boost strategic growth with in-depth market analysis - Get a free sample preview today!
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumptions
- Executive Summary
- The US 3D Bioprinting Market Policies, Regulations, and Product Standards
- The US 3D Bioprinting Market Trends & Developments
- The US 3D Bioprinting Market Dynamics
- Growth Drivers
- Challenges
- The US 3D Bioprinting Market Hotspot & Opportunities
- The US 3D Bioprinting Market Value Chain Analysis
- The US 3D Bioprinting Market Outlook, 2020-2030F
- Market Size & Outlook
- By Revenue (USD Million)
- Market Share & Outlook
- By Component
- 3D Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Micro Extrusion Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Inkjet 3D Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Laser-Assisted Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Stereolithography-Based Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Magnetic 3D Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Other 3D Bioprinters- Market Size & Forecast 2020-2030, USD Million
- Bioinks- Market Size & Forecast 2020-2030, USD Million
- Natural Bioinks- Market Size & Forecast 2020-2030, USD Million
- Hybrid Bioinks- Market Size & Forecast 2020-2030, USD Million
- Synthetic Bioinks- Market Size & Forecast 2020-2030, USD Million
- Software- Market Size & Forecast 2020-2030, USD Million
- Consumables- Market Size & Forecast 2020-2030, USD Million
- 3D Bioprinters- Market Size & Forecast 2020-2030, USD Million
- By Material
- Living Cells- Market Size & Forecast 2020-2030, USD Million
- Hydrogels- Market Size & Forecast 2020-2030, USD Million
- Extracellular Matrices- Market Size & Forecast 2020-2030, USD Million
- Other Materials- Market Size & Forecast 2020-2030, USD Million
- By Application
- Research Applications- Market Size & Forecast 2020-2030, USD Million
- Drug Research- Market Size & Forecast 2020-2030, USD Million
- Regenerative Medicine- Market Size & Forecast 2020-2030, USD Million
- 3D Cell Culture- Market Size & Forecast 2020-2030, USD Million
- Clinical Applications- Market Size & Forecast 2020-2030, USD Million
- Skin- Market Size & Forecast 2020-2030, USD Million
- Bone & Cartilage- Market Size & Forecast 2020-2030, USD Million
- Blood Vessels- Market Size & Forecast 2020-2030, USD Million
- Other Clinical Applications- Market Size & Forecast 2020-2030, USD Million
- Research Applications- Market Size & Forecast 2020-2030, USD Million
- By End User
- Academic & Research Institutes- Market Size & Forecast 2020-2030, USD Million
- Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2020-2030, USD Million
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- By Region
- North-East
- Mid-West
- West
- South
- By Company
- Company Revenue Shares
- Competitor Characteristics
- By Component
- Market Size & Outlook
- The US Living Cells 3D Bioprinting Market Outlook, 2020-2030F
- Market Size & Outlook
- By Revenue (USD Million)
- Market Share & Outlook
- By Component- Market Size & Forecast 2020-2030, USD Million
- By Application- Market Size & Forecast 2020-2030, USD Million
- By End User- Market Size & Forecast 2020-2030, USD Million
- Market Size & Outlook
- The US Hydrogels 3D Bioprinting Market Outlook, 2020-2030F
- Market Size & Outlook
- By Revenue (USD Million)
- Market Share & Outlook
- By Component- Market Size & Forecast 2020-2030, USD Million
- By Application- Market Size & Forecast 2020-2030, USD Million
- By End User- Market Size & Forecast 2020-2030, USD Million
- Market Size & Outlook
- The US Extracellular Matrices 3D Bioprinting Market Outlook, 2020-2030F
- Market Size & Outlook
- By Revenue (USD Million)
- Market Share & Outlook
- By Component- Market Size & Forecast 2020-2030, USD Million
- By Application- Market Size & Forecast 2020-2030, USD Million
- By End User- Market Size & Forecast 2020-2030, USD Million
- Market Size & Outlook
- The US 3D Bioprinting Market Key Strategic Imperatives for Success & Growth
- Competition Outlook
- Company Profiles
- CELLINK
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Organovo
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Aspect Biosystems
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Allevi
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Prellis Biologics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Stratasys
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Advanced Solutions Life Sciences, LLC
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- regenHU Ltd
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Poietis
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- 3D Bioprinting
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- CELLINK
- Company Profiles
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making